IL135303A0 - Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents - Google Patents
Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agentsInfo
- Publication number
- IL135303A0 IL135303A0 IL13530398A IL13530398A IL135303A0 IL 135303 A0 IL135303 A0 IL 135303A0 IL 13530398 A IL13530398 A IL 13530398A IL 13530398 A IL13530398 A IL 13530398A IL 135303 A0 IL135303 A0 IL 135303A0
- Authority
- IL
- Israel
- Prior art keywords
- antiallergic agents
- producing
- same
- alkyl
- chem
- Prior art date
Links
- 239000000043 antiallergic agent Substances 0.000 title abstract 2
- QDEVEJYEXBFIJD-UHFFFAOYSA-N triazolo[4,5-i][1]benzazepine Chemical class C1=CC2=CC=CC=NC2=C2C1=NN=N2 QDEVEJYEXBFIJD-UHFFFAOYSA-N 0.000 title abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26461197 | 1997-09-29 | ||
| JP5206398 | 1998-03-04 | ||
| PCT/JP1998/004363 WO1999016770A1 (fr) | 1997-09-29 | 1998-09-29 | Derives de triazolobenzazepine tricyclique, leur procede de production et antiallergique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL135303A0 true IL135303A0 (en) | 2001-05-20 |
Family
ID=26392670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13530398A IL135303A0 (en) | 1997-09-29 | 1998-09-29 | Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6372735B1 (hu) |
| EP (1) | EP1026167B1 (hu) |
| JP (1) | JP3188482B2 (hu) |
| KR (1) | KR100389140B1 (hu) |
| CN (2) | CN1155599C (hu) |
| AT (1) | ATE233764T1 (hu) |
| AU (1) | AU744636B2 (hu) |
| BR (1) | BR9814055B1 (hu) |
| CA (1) | CA2305307C (hu) |
| DE (1) | DE69811930T2 (hu) |
| DK (1) | DK1026167T3 (hu) |
| ES (1) | ES2191963T3 (hu) |
| HK (1) | HK1032782A1 (hu) |
| HU (1) | HUP0004020A3 (hu) |
| ID (1) | ID24101A (hu) |
| IL (1) | IL135303A0 (hu) |
| NO (2) | NO319542B1 (hu) |
| NZ (1) | NZ503601A (hu) |
| PL (1) | PL339544A1 (hu) |
| PT (1) | PT1026167E (hu) |
| RU (1) | RU2198885C2 (hu) |
| SK (1) | SK283869B6 (hu) |
| TR (1) | TR200000808T2 (hu) |
| TW (1) | TW510902B (hu) |
| WO (1) | WO1999016770A1 (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7002009B2 (en) * | 2001-12-26 | 2006-02-21 | Meiji Seika Kaisha, Ltd. | Crystalline tricyclic triazolobenzazepine derivative |
| ES2283781T3 (es) * | 2002-02-01 | 2007-11-01 | Meiji Seika Kaisha, Ltd. | Procedimiento para producir un compuesto de 1,2,3-triazol. |
| PL374860A1 (en) | 2002-07-09 | 2005-11-14 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| NZ537251A (en) | 2002-07-09 | 2007-02-23 | Bristol Myers Squibb Co | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| EP1642900A1 (en) * | 2003-06-19 | 2006-04-05 | Meiji Seika Kaisha Ltd. | Tricyclic triazolobenzazepine derivative produced as novel crystalline substance |
| US20070167402A1 (en) * | 2003-06-20 | 2007-07-19 | Meiji Seika Kaisha, Ltd. | Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same |
| ATE381566T1 (de) | 2004-05-14 | 2008-01-15 | Millennium Pharm Inc | Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase |
| EP1994931A4 (en) * | 2006-03-02 | 2010-12-01 | Meiji Seika Kaisha | PROPHYLACTIC OR THERAPEUTIC AGENT FOR ALLERGIC EYE DISEASES OR ALLERGIC NOSES DISEASES WITH A TRICOLOZENZOAZEPINE DERIVATIVE TRICYCLIC |
| WO2008040332A1 (de) * | 2006-09-25 | 2008-04-10 | Forschungsverbund Berlin E.V. | Strukturmimetika prolinreicher peptide und ihre pharmazeutische verwendung |
| CL2007003244A1 (es) | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
| ATE497386T1 (de) | 2007-12-18 | 2011-02-15 | Meiji Seika Kaisha | Vorbeuge- oder heilmittel für entzündliche darmerkrankungen |
| ES2468391T3 (es) | 2008-12-22 | 2014-06-16 | Millennium Pharmaceuticals, Inc. | Combinación de inhibidores de cinasas Aurora y anticuerpos anti-CD20 |
| JO3635B1 (ar) | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
| AU2010339691B2 (en) * | 2010-01-07 | 2015-04-02 | Alkermes Pharma Ireland Limited | Prodrugs of heteraromatic compounds |
| BR112012020557A8 (pt) | 2010-02-19 | 2018-01-02 | Millennium Pharm Inc | formas cristalinas de 4-{[9-cloro-7-(2-flúor-6-metoifenil)-5h-pirimido[5,4-d][2]benzazepin-2-il]amino}-2-metoxibenzoato de sódio |
| US20130303519A1 (en) | 2012-03-20 | 2013-11-14 | Millennium Pharmaceuticals, Inc. | Methods of treating cancer using aurora kinase inhibitors |
| CA2907726A1 (en) | 2013-03-22 | 2014-09-25 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mtorc1/2 inhibitors and selective inhibitors of aurora a kinase |
| EP3324976A4 (en) | 2015-07-21 | 2019-03-27 | Millennium Pharmaceuticals, Inc. | ADMINISTRATION OF KINASE AURORA INHIBITOR AND CHEMOTHERAPEUTIC AGENTS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2156933T3 (es) * | 1993-12-28 | 2001-08-01 | Meiji Seika Co | Derivados triciclicos de benzazepina y benzotiazepina. |
| EP0834512A4 (en) * | 1995-06-15 | 2001-08-22 | Meiji Seika Kaisha | TRICLYCLIC BENZAZEPINE COMPOUNDS. |
| WO1997032883A1 (en) * | 1996-03-08 | 1997-09-12 | Zeneca Limited | Azolobenzazepine derivatives as neurologically active agents |
| US20070059533A1 (en) * | 2005-09-12 | 2007-03-15 | Burdette Steven R | Thermal reflow of glass and fused silica body |
-
1998
- 1998-09-29 ID IDW20000808A patent/ID24101A/id unknown
- 1998-09-29 IL IL13530398A patent/IL135303A0/xx unknown
- 1998-09-29 ES ES98944289T patent/ES2191963T3/es not_active Expired - Lifetime
- 1998-09-29 KR KR10-2000-7003362A patent/KR100389140B1/ko not_active IP Right Cessation
- 1998-09-29 AT AT98944289T patent/ATE233764T1/de active
- 1998-09-29 CA CA002305307A patent/CA2305307C/en not_active Expired - Fee Related
- 1998-09-29 WO PCT/JP1998/004363 patent/WO1999016770A1/ja not_active Application Discontinuation
- 1998-09-29 PL PL98339544A patent/PL339544A1/xx unknown
- 1998-09-29 PT PT98944289T patent/PT1026167E/pt unknown
- 1998-09-29 US US09/509,494 patent/US6372735B1/en not_active Expired - Lifetime
- 1998-09-29 BR BRPI9814055-8A patent/BR9814055B1/pt not_active IP Right Cessation
- 1998-09-29 HU HU0004020A patent/HUP0004020A3/hu unknown
- 1998-09-29 AU AU91869/98A patent/AU744636B2/en not_active Ceased
- 1998-09-29 CN CNB98810735XA patent/CN1155599C/zh not_active Expired - Fee Related
- 1998-09-29 DE DE69811930T patent/DE69811930T2/de not_active Expired - Lifetime
- 1998-09-29 SK SK425-2000A patent/SK283869B6/sk unknown
- 1998-09-29 CN CNB2003101047539A patent/CN1312135C/zh not_active Expired - Fee Related
- 1998-09-29 EP EP98944289A patent/EP1026167B1/en not_active Expired - Lifetime
- 1998-09-29 RU RU2000111517/04A patent/RU2198885C2/ru not_active IP Right Cessation
- 1998-09-29 NZ NZ503601A patent/NZ503601A/en unknown
- 1998-09-29 TW TW087116198A patent/TW510902B/zh not_active IP Right Cessation
- 1998-09-29 TR TR2000/00808T patent/TR200000808T2/xx unknown
- 1998-09-29 JP JP51996999A patent/JP3188482B2/ja not_active Expired - Fee Related
- 1998-09-29 DK DK98944289T patent/DK1026167T3/da active
-
2000
- 2000-03-23 NO NO20001500A patent/NO319542B1/no unknown
-
2001
- 2001-05-22 HK HK01103502A patent/HK1032782A1/xx not_active IP Right Cessation
-
2002
- 2002-02-13 US US10/073,326 patent/US7022860B2/en not_active Expired - Fee Related
-
2004
- 2004-09-08 NO NO20043765A patent/NO20043765L/no not_active Application Discontinuation
-
2005
- 2005-11-09 US US11/269,828 patent/US7238812B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL135303A0 (en) | Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents | |
| BE2018C008I2 (hu) | ||
| DK1029853T3 (da) | Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler | |
| HUT63155A (en) | Process for producing substituted taxane derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT74182A (en) | Novel imidazole derivatives, process for producing the same and pharmaceutical compositions containing the compounds | |
| BR9805734A (pt) | Derivados de imidazolin-4-ona úteis como agentes anticancerìgenos. | |
| HK1019878A1 (en) | Total synthesis of antitumor acylfulvenes. | |
| CA2240927A1 (en) | Process for production of piperidine derivatives | |
| EP1110961A4 (en) | OXYGEN HETEROCYCLIC COMPOUNDS | |
| EP0937726A4 (en) | INTERMEDIATE PRODUCTS FOR PRODUCING DUOCARMYCIN-SA AND DERIVATIVES THEREOF, AND A METHOD FOR PRODUCING THE INTERIM PRODUCTS | |
| AU3415599A (en) | Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents | |
| IL114785A0 (en) | Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them | |
| EP1094055A4 (en) | NEW VINYLBENZENE DERIVATIVES | |
| HUP0004413A2 (hu) | 2-Aril-3-aroil-benzo[b]tiofének alkalmazása ösztrogén elvonási szindróma kezelésére alkalmas gyógyszerkészítmények előállítására | |
| IE901314L (en) | 2- substituted-n,n'-di(trimethoxybenzoyl)piperazines | |
| HK1033455A1 (en) | Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same | |
| EP1072582A4 (en) | INTERMEDIATES IN THE SYNTHESIS OF A RING UNIT OF THE VITAMIN DERIVATIVES SUBSTITUTED IN POSITION 2 | |
| EP0798304A4 (en) | DRUGS AGAINST TRHOMBOCYTOPENIA | |
| EP1197211A4 (en) | CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS | |
| AR017971A1 (es) | DERIVADOS TRICíCLICOS DE TRIAZOLBENZAZEPINAS, PROCEDIMIENTO PARA PRODUCIR LOS MISMOS, COMPOSICIONES FARMACEUTICAS FORMULADAS CON DICHOS COMPUESTOS Y COMPUESTOS INTERMEDIARIOS DE APLICACION EN DICHO PROCEDIMIENTO Y LA PEPARACION DE LOS MISMOS. | |
| EP1251129A4 (en) | PYRIMIDINE DERIVATIVES WITH ANTI-TUMOR EFFECT | |
| EP0502488A3 (en) | Phosphorus-containing azetidin-2-one derivatives |